289 related articles for article (PubMed ID: 32278720)
1. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line.
Faghfoori MH; Nosrati H; Rezaeejam H; Charmi J; Kaboli S; Johari B; Danafar H
Int J Pharm; 2020 May; 582():119320. PubMed ID: 32278720
[TBL] [Abstract][Full Text] [Related]
2. Facile green synthesis of bismuth sulfide radiosensitizer
Nosrati H; Abhari F; Charmi J; Rahmati M; Johari B; Azizi S; Rezaeejam H; Danafar H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3832-3838. PubMed ID: 31556316
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery.
Nosrati H; Abhari F; Charmi J; Davaran S; Danafar H
Bioorg Chem; 2019 Jul; 88():102959. PubMed ID: 31075743
[TBL] [Abstract][Full Text] [Related]
4. Renal Clearable Bi-Bi
Dong L; Zhang P; Liu X; Deng R; Du K; Feng J; Zhang H
ACS Appl Mater Interfaces; 2019 Feb; 11(8):7774-7781. PubMed ID: 30698406
[TBL] [Abstract][Full Text] [Related]
5. One-pot synthesis of AIE based bismuth sulfide nanotheranostics for fluorescence imaging and photothermal therapy.
Wang K; Zhuang J; Chen L; Xu D; Zhang X; Chen Z; Wei Y; Zhang Y
Colloids Surf B Biointerfaces; 2017 Dec; 160():297-304. PubMed ID: 28950194
[TBL] [Abstract][Full Text] [Related]
6. Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer.
Nosrati H; Ghaffarlou M; Salehiabar M; Mousazadeh N; Abhari F; Barsbay M; Ertas YN; Rashidzadeh H; Mohammadi A; Nasehi L; Rezaeejam H; Davaran S; Ramazani A; Conde J; Danafar H
Biomater Adv; 2022 Sep; 140():213090. PubMed ID: 36027669
[TBL] [Abstract][Full Text] [Related]
7. Integration of Fe
Luo K; Zhao J; Jia C; Chen Y; Zhang Z; Zhang J; Huang M; Wang S
ACS Appl Mater Interfaces; 2020 May; 12(20):22650-22660. PubMed ID: 32330380
[TBL] [Abstract][Full Text] [Related]
8. Tumor Targeted Albumin Coated Bismuth Sulfide Nanoparticles (Bi
Nosrati H; Charmi J; Salehiabar M; Abhari F; Danafar H
ACS Biomater Sci Eng; 2019 Sep; 5(9):4416-4424. PubMed ID: 33438407
[TBL] [Abstract][Full Text] [Related]
9. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
10. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
11. In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug methotrexate to MCF-7 breast cancer cells.
Murawala P; Tirmale A; Shiras A; Prasad BL
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():158-67. PubMed ID: 24268245
[TBL] [Abstract][Full Text] [Related]
12. Folate-methotrexate loaded bovine serum albumin nanoparticles preparation: an
Al-Rahim AM; AlChalabi R; Al-Saffar AZ; Sulaiman GM; Albukhaty S; Belali T; Ahmed EM; Khalil KAA
Anim Biotechnol; 2023 Apr; 34(2):166-182. PubMed ID: 34319853
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
14. Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.
Wang J; Zhang Z; Ai Y; Liu F; Chen MM; Liu D
Carbohydr Res; 2021 Mar; 501():108275. PubMed ID: 33657498
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of PEGylated Fe@Bi
Li E; Cheng X; Deng Y; Zhu J; Xu X; Saw PE; Gu H; Ge C; Pan Y
Biomater Sci; 2018 Jun; 6(7):1892-1898. PubMed ID: 29870037
[TBL] [Abstract][Full Text] [Related]
16. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery.
Salehiabar M; Nosrati H; Javani E; Aliakbarzadeh F; Kheiri Manjili H; Davaran S; Danafar H
Int J Biol Macromol; 2018 Aug; 115():83-89. PubMed ID: 29653171
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.
Trapani A; Denora N; Iacobellis G; Sitterberg J; Bakowsky U; Kissel T
AAPS PharmSciTech; 2011 Dec; 12(4):1302-11. PubMed ID: 21948322
[TBL] [Abstract][Full Text] [Related]
18. Redox/photo dual-responsive, self-targeted, and photosensitizer-laden bismuth sulfide nanourchins for combination therapy in cancer.
Poudel K; Banstola A; Gautam M; Soe ZC; Pham LM; Jeong JH; Choi HG; Ku SK; Yong CS; Tran TH; Kim JO
Nanoscale; 2021 Jan; 13(2):1231-1247. PubMed ID: 33406178
[TBL] [Abstract][Full Text] [Related]
19. Autophagic blockage by bismuth sulfide nanoparticles inhibits migration and invasion of HepG2 cells.
Hao BM; Liu YN; Zhang CY; Li GQ; Wang WN; Xu WD; Zha ZB; Wang F; Li C; Miao ZH; Yang XX; Chen YL; Qian HS; Zhou W
Nanotechnology; 2020 Nov; 31(46):465102. PubMed ID: 32857735
[TBL] [Abstract][Full Text] [Related]
20. Evaluation radioprotective effect of curcumin conjugated albumin nanoparticles.
Nosrati H; Danafar H; Rezaeejam H; Gholipour N; Rahimi-Nasrabadi M
Bioorg Chem; 2020 Jul; 100():103891. PubMed ID: 32422388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
